Exposure to endocrine disruptors varies geographically and temporally. Environmental levels of persistent organic pollutants have decreased after international regulation, whereas potential exposure to thousands of new chemicals has increased. The adverse effects of endocrine disruptors depend on susceptibility and timing of the exposure. Fetal and childhood exposures are often most harmful because of organizational and programming effects. In this review, we use the exposure to persistent organic pollutants such as polybrominated diphenyl ethers, dioxins and dioxin-like polychlorinated biphenyls and differences in the incidence of reproductive disorders between Denmark and Finland as an example to highlight how exposure variation and variation in genetic susceptibility may influence the strength of the association between the exposure to endocrine disruptors and adverse effects. Understanding the causes and implications of interindividual differences in susceptibility to endocrine disruptors is crucial for the protection of normal development.

Keywords:
Testis, Endocrine disruptor, Sperm, Cryptorchidism, Dioxin
1.
Bergman Å, Heindel J, Jobling S, Kidd A, Zoeller T (eds): State of the science of endocrine disrupting chemicals - 2012. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme and World Health Organization 2013. http://www.who.int/iris/bitstream/10665/78101/1/9789241505031_eng.pdf?ua=1 (accessed May 12, 2015).
2.
Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al: Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015;100:1245-1255.
3.
Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L: Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015;100:1256-1266.
4.
Hauser R, Skakkebaek NE, Hass U, Toppari J, Juul A, Andersson AM, et al: Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015;100:1267-1277.
5.
Toppari J, Larsen JC, Christiansen P, Giwercman a, Grandjean P, Guillette LJ, et al: Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104(suppl):741-803.
6.
Jensen TK, Vierula M, Hjollund NH, Saaranen M, Scheike T, Saarikoski S, et al: Semen quality among Danish and Finnish men attempting to conceive. The Danish First Pregnancy Planner Study Team. Eur J Endocrinol 2000;142:47-52.
7.
Skakkebæk NE, Rajpert-de Meyts E, Main KM: Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects 2001;16:972-978.
8.
Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, et al: Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363:1264-1269.
9.
Boisen KA, Chellakooty M, Schmidt IM, Kai CM, Damgaard IN, Suomi AM, et al: Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab 2005;90:4041-4046.
10.
Virtanen HE, Kaleva M, Haavisto AM, Schmidt IM, Chellakooty M, Main KM, et al: The birth rate of hypospadias in the Turku area in Finland. APMIS 2001;109:96-100.
11.
Jørgensen N, Andersen AG, Eustache F, Irvine DS, Suominen J, Petersen JH, et al: Regional differences in semen quality in Europe. Hum Reprod 2001;16:1012-1019.
12.
Jørgensen N, Carlsen E, Nermoen I, Punab M, Suominen J, Andersen AG, et al: East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002;17:2199-2208.
13.
Le Cornet C, Lortet-Tieulent J, Forman D, Béranger R, Flechon A, Fervers B, et al: Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 2014;50:831-839.
14.
Krysiak-Baltyn K, Toppari J, Skakkebaek NE, Jensen TS, Virtanen HE, Schramm KW, et al: Association between chemical pattern in breast milk and congenital cryptorchidism: modelling of complex human exposures. Int J Androl 2012;35:294-302.
15.
Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al: Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 2006;114:270-276.
16.
Damgaard IN, Skakkebæk NE, Toppari J, Virtanen HE, Shen H, Schramm KW, et al: Persistent pesticides in human breast Milk and cryptorchidism. Environ Health Perspect 2006;114:1133-1138.
17.
Main KM, Kiviranta H, Virtanen HE, Sundqvist E, Tuomisto JT, Tuomisto J, et al: Flame retardants in placenta and breast milk and cryptorchidism in newborn boys. Environ Health Perspect 2007;115:1519-1526.
18.
Shen H, Main KM, Virtanen HE, Damggard IN, Haavisto A-M, Kaleva M, et al: From mother to child: investigation of prenatal and postnatal exposure to persistent bioaccumulating toxicants using breast milk and placenta biomonitoring. Chemosphere 2007;67:S256-S262.
19.
Shen H, Main KM, Kaleva M, Virtanen H, Haavisto AM, Skakkebaek NE, et al: Prenatal organochlorine pesticides in placentas from Finland: exposure of male infants born during 1997-2001. Placenta 2005;26:512-514.
20.
Pohjanvirta R, Tuomisto J: Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev 1994;46:483-549.
21.
WHO Task Group on Environmental Health Criteria: Environmental health criteria 88. Polychlorinated dibenzo-para-dioxins and dibenzofurans. IPCS (The International Programme on Chemical Safety) 1989. http://www.inchem.org/documents/ehc/ehc/ehc88.htm (accessed May 12, 2015).
22.
WHO Task Group on Environmental Health Criteria for Polychlorinated Biphenyls (PCBs) and Polychlorinated Terphenyls (PCTs): Environmental health criteria 140. Polychlorinated biphenyls and terphenyls (second edition). IPCS (The International Programme on Chemical Safety) 1993. http://www.inchem.org/documents/ehc/ehc/ehc140.htm (accessed February 23, 2916).
23.
Secretariat of the Stockholm Convention: The 12 initial POPs under the Stockholm Convention. http://chm.pops.int/TheConvention/ThePOPs/The12InitialPOPs/tabid/296/Default.aspx (accessed February 23, 2015).
24.
Oehme M, Biseth A, Schlabach M, Wiig Ø: Concentrations of polychlorinated dibenzo-p-dioxins, dibenzofurans and non-ortho substituted biphenyls in polar bear milk from Svalbard (Norway). Environ Pollut 1995;90:401-407.
25.
Krysiak-Baltyn K, Toppari J, Skakkebaek NE, Jensen TS, Virtanen HE, Schramm KW, et al: Country-specific chemical signatures of persistent environmental compounds in breast milk. Int J Androl 2010;33:270-278.
26.
Virtanen HE, Koskenniemi JJ, Sundqvist E, Main KM, Kiviranta H, Tuomisto JT, et al: Associations between congenital cryptorchidism in newborn boys and levels of dioxins and PCBs in placenta. Int J Androl 2012;35:283-293.
27.
Koskenniemi JJ, Virtanen HE, Kiviranta H, Damgaard IN, Matomäki J, Thorup JM, et al: Association between levels of persistent organic pollutants in adipose tissue and cryptorchidism in early childhood: a case-control study. Environ Heal 2015;14:78.
28.
Van den Berg M, Birnbaum L, Bosveld A, Brunström B, Cook P, Feeley M, et al: Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998;106:775-792.
29.
Frederiksen M, Vorkamp K, Thomsen M, Knudsen LE: Human internal and external exposure to PBDEs - a review of levels and sources. Int J Hyg Environ Health 2009;212:109-134.
30.
de Wit CA, Björklund JA, Thuresson K: Tri-decabrominated diphenyl ethers and hexabromocyclododecane in indoor air and dust from Stockholm microenvironments 2: indoor sources and human exposure. Environ Int 2012;39:141-147.
31.
Colciago A, Casati L, Mornati O, Vergoni AV, Santagostino A, Celotti F, et al: Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 2: effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring. Toxicol Appl Pharmacol 2009;239:46-54.
32.
Mably TA, Moore RW, Peterson RE: In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status. Toxicol Appl Pharmacol 1992;114:97-107.
33.
Kuriyama SN, Talsness CE, Grote K, Chahoud I: Developmental exposure to low-dose PBDE-99: effects on male fertility and neurobehavior in rat offspring. Environ Health Perspect 2004;113:149-154.
34.
Morton T: The Surgical Anatomy of Inguinal Herniae, the Testis and Its Coverings. London, Taylor and Walton, 1841.
35.
Mocarelli P, Gerthoux PM, Patterson DG, Milani S, Limonta G, Bertona M, et al: Dioxin exposure, from infancy through puberty, produces endocrine disruption and affects human semen quality. Environ Health Perspect 2008;116:70-77.
36.
Mocarelli P, Gerthoux PM, Needham LL, Patterson DG, Limonta G, Falbo R, et al: Perinatal exposure to low doses of dioxin can permanently impair human semen quality. Environ Health Perspect 2011;119:713-718.
37.
Johnson L, Petty CS, Neaves WB: Influence of age on sperm production and testicular weights in men. J Reprod Fertil 1984;70:211-218.
38.
Cortes D, Müller J, Skakkebaek NE: Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 1987;10:589-596.
39.
Fürst P: Dioxins, polychlorinated biphenyls and other organohalogen compounds in human milk. Levels, correlations, trends and exposure through breastfeeding. Mol Nutr Food Res 2006;50:922-933.
40.
Kiviranta H, Tuomisto JT, Tuomisto J, Tukiainen E, Vartiainen T: Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in the general population in Finland. Chemosphere 2005;60:854-869.
41.
Vinggaard A, Niemelä J: Screening of 397 chemicals and development of a quantitative structure - activity relationship model for androgen receptor antagonism. Chem Res 2008;813-823.
42.
Jacobsen PR, Christiansen S, Boberg J, Nellemann C, Hass U: Combined exposure to endocrine disrupting pesticides impairs parturition, causes pup mortality and affects sexual differentiation in rats. Int J Androl 2010;33:434-442.
43.
Rider C V, Wilson VS, Howdeshell KL, Hotchkiss AK, Furr JR, Lambright CR, et al: Cumulative effects of in utero administration of mixtures of ‘antiandrogens' on male rat reproductive development. Toxicol Pathol 2009;37:100-113.
44.
Pohjanvirta R, Wong JM, Li W, Harper PA, Tuomisto J, Okey AB: Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol Pharmacol 1998;54:86-93.
45.
Simanainen U, Adamsson A, Tuomisto JT, Miettinen HM, Toppari J, Tuomisto J, et al: Adult 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure and effects on male reproductive organs in three differentially TCDD-susceptible rat lines. Toxicol Sci 2004;81:401-407.
46.
Simanainen U, Haavisto T, Tuomisto JT, Paranko J, Toppari J, Tuomisto J, et al: Pattern of male reproductive system effects after in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in three differentially TCDD-sensitive rat lines. Toxicol Sci 2004;80:101-108.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.